3/10/2023 | Credit Suisse Group | Lower Target | Outperform | $305.00 ➝ $250.00 | Low | |
3/9/2023 | Piper Sandler | Reiterated Rating | Overweight | $270.00 | Low | |
3/9/2023 | The Goldman Sachs Group | Lower Target | Buy | $325.00 ➝ $280.00 | Low | |
3/9/2023 | Royal Bank of Canada | Reiterated Rating | Outperform | $235.00 | Low | |
3/9/2023 | Needham & Company LLC | Boost Target | Buy | $240.00 ➝ $250.00 | Low | |
3/9/2023 | Wedbush | Lower Target | | $240.00 ➝ $230.00 | Low | |
3/9/2023 | Mizuho | Lower Target | Neutral | $220.00 ➝ $180.00 | Low | |
3/9/2023 | Oppenheimer | Lower Target | Outperform | $320.00 ➝ $270.00 | Low | |
3/9/2023 | JMP Securities | Boost Target | Market Outperform | $215.00 ➝ $245.00 | Low | |
3/9/2023 | Barclays | Lower Target | Overweight | $264.00 ➝ $257.00 | Low | |
3/7/2023 | Citigroup | Lower Target | Buy | $300.00 ➝ $295.00 | Low | |
2/23/2023 | Stifel Nicolaus | Lower Target | | $256.00 ➝ $240.00 | Low | |
2/17/2023 | Sanford C. Bernstein | Initiated Coverage | Outperform | $282.00 | Low | |
2/15/2023 | Mizuho | Boost Target | Neutral | $170.00 ➝ $220.00 | Low | |
2/15/2023 | Barclays | Boost Target | Overweight | $240.00 ➝ $264.00 | Low | |
2/6/2023 | KeyCorp | Boost Target | Overweight | $220.00 ➝ $255.00 | Low | |
1/26/2023 | Guggenheim | Initiated Coverage | Neutral | $205.00 | Low | |
1/9/2023 | Truist Financial | Lower Target | | $300.00 ➝ $235.00 | Low | |
12/21/2022 | Needham & Company LLC | Boost Target | Buy | $225.00 ➝ $240.00 | Low | |
12/15/2022 | Tigress Financial | Lower Target | Buy | $575.00 ➝ $365.00 | Low | |
12/14/2022 | Wedbush | Initiated Coverage | Outperform | $240.00 | Low | |
12/7/2022 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $300.00 ➝ $270.00 | Low | |
12/7/2022 | The Goldman Sachs Group | Lower Target | Buy | $380.00 ➝ $325.00 | Low | |
12/7/2022 | Oppenheimer | Lower Target | Outperform | $375.00 ➝ $320.00 | Low | |
12/7/2022 | Needham & Company LLC | Lower Target | Buy | $330.00 ➝ $225.00 | Low | |
12/7/2022 | Morgan Stanley | Boost Target | Equal Weight | $215.00 ➝ $230.00 | Low | |
12/7/2022 | Citigroup | Boost Target | | $295.00 ➝ $300.00 | Low | |
12/7/2022 | Robert W. Baird | Boost Target | | $205.00 ➝ $230.00 | Low | |
12/7/2022 | Credit Suisse Group | Lower Target | Outperform | $400.00 ➝ $305.00 | Low | |
12/7/2022 | Barclays | Boost Target | Overweight | $233.00 ➝ $240.00 | Low | |
12/7/2022 | Mizuho | Lower Target | Neutral | $190.00 ➝ $170.00 | Low | |
12/7/2022 | UBS Group | Boost Target | Buy | $200.00 ➝ $215.00 | Low | |
12/7/2022 | JMP Securities | Upgrade | Market Perform ➝ Outperform | $215.00 | Low | |
12/5/2022 | Robert W. Baird | Lower Target | Outperform | $330.00 ➝ $205.00 | Low | |
11/29/2022 | UBS Group | Lower Target | Buy | $390.00 ➝ $200.00 | Low | |
11/21/2022 | KeyCorp | Initiated Coverage | Overweight | $215.00 | Low | |
11/21/2022 | Morgan Stanley | Downgrade | Overweight ➝ Equal Weight | $368.00 ➝ $215.00 | Low | |
11/18/2022 | Barclays | Lower Target | Overweight | $300.00 ➝ $233.00 | Low | |
11/15/2022 | Mizuho | Lower Target | Neutral | $300.00 ➝ $190.00 | Low | |
10/20/2022 | Piper Sandler | Lower Target | Overweight | $350.00 ➝ $270.00 | Low | |
10/18/2022 | Redburn Partners | Upgrade | Sell ➝ Neutral | | Low | |
10/18/2022 | Barclays | Lower Target | Overweight | $360.00 ➝ $300.00 | Low | |
9/30/2022 | Truist Financial | Initiated Coverage | Buy | $300.00 | Low | |
9/6/2022 | The Goldman Sachs Group | Lower Target | | $430.00 | Low | |
9/1/2022 | Canaccord Genuity Group | Boost Target | Buy | $300.00 ➝ $360.00 | Low | |
9/1/2022 | Canaccord Genuity Group | Boost Target | Buy ➝ Buy | $300.00 ➝ $360.00 | Low | |
9/1/2022 | Needham & Company LLC | Lower Target | Buy | $350.00 ➝ $330.00 | Low | |
9/1/2022 | Stifel Nicolaus | Lower Target | Buy ➝ Buy | $340.00 ➝ $320.00 | Low | |
9/1/2022 | Robert W. Baird | Lower Target | Outperform | $360.00 ➝ $330.00 | Low | |
9/1/2022 | Royal Bank of Canada | Lower Target | Outperform | $400.00 ➝ $350.00 | Low | |
9/1/2022 | Credit Suisse Group | Lower Target | Outperform | $500.00 ➝ $400.00 | Low | |
9/1/2022 | UBS Group | Lower Target | Buy | $430.00 ➝ $390.00 | Low | |
9/1/2022 | Citigroup | Lower Target | Buy | $450.00 ➝ $445.00 | Low | |
9/1/2022 | Barclays | Lower Target | Overweight | $438.00 ➝ $360.00 | Low | |
9/1/2022 | Piper Sandler | Lower Target | Overweight | $375.00 ➝ $350.00 | Low | |
8/22/2022 | Citigroup | Boost Target | | $425.00 ➝ $450.00 | Low | |
8/17/2022 | Mizuho | Boost Target | Buy | $270.00 ➝ $390.00 | Low | |
8/16/2022 | Barclays | Boost Target | Overweight | $338.00 ➝ $438.00 | Low | |
7/18/2022 | Piper Sandler | Lower Target | Overweight | $430.00 ➝ $375.00 | Low | |
7/12/2022 | Robert W. Baird | Initiated Coverage | Outperform | $360.00 | Low | |
6/29/2022 | Redburn Partners | Initiated Coverage | Sell | $190.00 | Low | |
6/10/2022 | Needham & Company LLC | Boost Target | Buy | $310.00 ➝ $350.00 | High | |
6/9/2022 | Royal Bank of Canada | Boost Target | | $325.00 ➝ $375.00 | Medium | |
6/8/2022 | UBS Group | Boost Target | Buy | $315.00 ➝ $345.00 | Low | |
6/2/2022 | Morgan Stanley | Lower Target | Overweight | $378.00 ➝ $368.00 | High | |
6/2/2022 | Citigroup | Boost Target | | $405.00 ➝ $425.00 | High | |
6/2/2022 | Needham & Company LLC | Lower Target | Buy | $362.00 ➝ $310.00 | High | |
6/2/2022 | Stifel Nicolaus | Lower Target | | $425.00 ➝ $340.00 | High | |
6/2/2022 | Canaccord Genuity Group | Lower Target | | $400.00 ➝ $300.00 | High | |
6/2/2022 | Credit Suisse Group | Lower Target | Outperform | $650.00 ➝ $500.00 | High | |
6/2/2022 | Oppenheimer | Lower Target | Outperform | $490.00 ➝ $400.00 | High | |
6/2/2022 | Barclays | Boost Target | Overweight | $330.00 ➝ $338.00 | High | |
6/2/2022 | Piper Sandler | Lower Target | Overweight | $585.00 ➝ $430.00 | High | |
6/1/2022 | Citigroup | Lower Target | Buy | $525.00 ➝ $405.00 | High | |
5/24/2022 | William Blair | Reiterated Rating | Outperform | | High | |
5/20/2022 | Barclays | Lower Target | Overweight | $410.00 ➝ $330.00 | Low | |
5/19/2022 | Morgan Stanley | Lower Target | Overweight | $475.00 ➝ $378.00 | Medium | |
5/18/2022 | Mizuho | Lower Target | Neutral | $325.00 ➝ $270.00 | High | |
3/18/2022 | UBS Group | Upgrade | Neutral ➝ Buy | $345.00 ➝ $450.00 | High | |
3/16/2022 | Morgan Stanley | Lower Target | Overweight | $633.00 ➝ $475.00 | High | |
3/9/2022 | Canaccord Genuity Group | Lower Target | | $560.00 ➝ $400.00 | High | |
3/9/2022 | Stifel Nicolaus | Lower Target | | $550.00 ➝ $425.00 | High | |
3/9/2022 | Needham & Company LLC | Lower Target | Buy | $626.00 ➝ $362.00 | High | |
3/9/2022 | Credit Suisse Group | Lower Target | Outperform | $700.00 ➝ $650.00 | High | |
3/9/2022 | Mizuho | Lower Target | Neutral | $400.00 ➝ $325.00 | High | |
3/9/2022 | Oppenheimer | Lower Target | | $510.00 ➝ $410.00 | High | |
3/9/2022 | Barclays | Lower Target | Overweight | $556.00 ➝ $410.00 | High | |
3/1/2022 | Royal Bank of Canada | Initiated Coverage | Outperform | $505.00 | Low | |
2/15/2022 | Mizuho | Lower Target | Neutral | $490.00 ➝ $400.00 | Medium | |
2/11/2022 | Tigress Financial | Initiated Coverage | Buy | $630.00 | Low | |
1/12/2022 | Barclays | Lower Target | | $590.00 ➝ $556.00 | Medium | |
12/16/2021 | Morgan Stanley | Boost Target | Overweight | $525.00 ➝ $633.00 | High | |
12/8/2021 | The Goldman Sachs Group | Boost Target | Buy | $475.00 ➝ $545.00 | High | |
12/7/2021 | Morgan Stanley | Boost Target | Overweight ➝ Overweight | $480.00 ➝ $525.00 | High | |
12/7/2021 | Stifel Nicolaus | Boost Target | Buy | $495.00 ➝ $550.00 | High | |
12/7/2021 | Needham & Company LLC | Boost Target | Buy ➝ Buy | $534.00 ➝ $626.00 | High | |
12/7/2021 | Citigroup | Boost Target | Buy | $526.00 ➝ $660.00 | High | |
12/7/2021 | Mizuho | Boost Target | Neutral | $475.00 ➝ $490.00 | High | |
12/7/2021 | Piper Sandler | Boost Target | Overweight ➝ Overweight | $525.00 ➝ $585.00 | High | |
11/16/2021 | Credit Suisse Group | Initiated Coverage | Outperform | $700.00 | High | |
11/15/2021 | Mizuho | Boost Target | Neutral | $410.00 ➝ $475.00 | Low | |
9/17/2021 | Barclays | Boost Target | Overweight | $505.00 ➝ $590.00 | Medium | |
9/7/2021 | Argus | Boost Target | Buy | $406.00 ➝ $550.00 | High | |
9/3/2021 | The Goldman Sachs Group | Reiterated Rating | Buy | $475.00 | N/A | |
9/3/2021 | Oppenheimer | Boost Target | Outperform | $400.00 ➝ $470.00 | High | |
9/3/2021 | Morgan Stanley | Boost Target | Overweight | $410.00 ➝ $480.00 | High | |
9/3/2021 | Barclays | Boost Target | Overweight ➝ Overweight | $420.00 ➝ $505.00 | High | |
9/3/2021 | Piper Sandler | Boost Target | Overweight | $425.00 ➝ $525.00 | High | |
9/3/2021 | Needham & Company LLC | Boost Target | Buy | $415.00 ➝ $534.00 | High | |
9/3/2021 | Stifel Nicolaus | Boost Target | Buy | $384.00 ➝ $495.00 | High | |
9/3/2021 | UBS Group | Boost Target | Neutral | $300.00 ➝ $450.00 | High | |
9/3/2021 | Mizuho | Boost Target | Neutral | $350.00 ➝ $410.00 | High | |
9/3/2021 | Citigroup | Reiterated Rating | Buy | $450.00 ➝ $526.00 | High | |
8/24/2021 | Needham & Company LLC | Initiated Coverage | Buy | $415.00 | Low | |
8/24/2021 | Morgan Stanley | Boost Target | Overweight | $377.00 ➝ $410.00 | Medium | |
8/23/2021 | Barclays | Boost Target | Overweight | $390.00 ➝ $420.00 | Medium | |
7/14/2021 | Needham & Company LLC | Initiated Coverage | Buy | $415.00 | Low | |
7/14/2021 | Mizuho | Boost Target | Neutral | $300.00 ➝ $320.00 | High | |
6/4/2021 | Needham & Company LLC | Boost Target | Buy | $409.00 ➝ $415.00 | High | |
6/4/2021 | Mizuho | Boost Target | Positive ➝ Neutral | $265.00 ➝ $300.00 | High | |
6/4/2021 | UBS Group | Lower Target | Neutral | $325.00 ➝ $300.00 | High | |
6/4/2021 | Citigroup | Boost Target | Buy | $445.00 ➝ $450.00 | High | |
5/25/2021 | Morgan Stanley | Lower Target | Overweight | $415.00 ➝ $377.00 | Low | |
5/14/2021 | The Goldman Sachs Group | Initiated Coverage | Buy | $310.00 | High | |
5/13/2021 | Mizuho | Lower Target | Neutral | $320.00 ➝ $265.00 | High | |
4/12/2021 | Mizuho | Initiated Coverage | Neutral | $320.00 | Medium | |
3/23/2021 | UBS Group | Initiated Coverage | Neutral | $325.00 | Low | |
3/12/2021 | Argus | Upgrade | Hold ➝ Buy | $406.00 | Medium | |
3/10/2021 | Morgan Stanley | Lower Target | Overweight | $439.00 ➝ $415.00 | High | |
3/10/2021 | Needham & Company LLC | Boost Target | Buy | $394.00 ➝ $409.00 | High | |
3/10/2021 | DA Davidson | Boost Target | Positive ➝ Neutral | $275.00 ➝ $300.00 | High | |
2/23/2021 | Citigroup | Boost Target | Buy | $465.00 ➝ $500.00 | High | |
1/19/2021 | Needham & Company LLC | Boost Target | Buy | $341.00 ➝ $394.00 | Low | |
1/13/2021 | Smith Barney Citigroup | Boost Target | | $354.00 ➝ $465.00 | Low | |
1/11/2021 | Piper Sandler | Boost Target | | $328.00 ➝ $425.00 | Medium | |
1/11/2021 | Barclays | Boost Target | Overweight | $331.00 ➝ $435.00 | Low | |
1/6/2021 | Macquarie | Initiated Coverage | Outperform | | N/A | |
1/5/2021 | Oppenheimer | Boost Target | Outperform | $300.00 ➝ $400.00 | N/A | |
12/17/2020 | Morgan Stanley | Upgrade | Equal Weight ➝ Overweight | $295.00 ➝ $439.00 | High | |
12/9/2020 | DA Davidson | Boost Target | Neutral | $250.00 ➝ $275.00 | High | |
12/9/2020 | Piper Sandler | Boost Target | Overweight | $310.00 ➝ $328.00 | High | |
12/9/2020 | Needham & Company LLC | Boost Target | Buy | $290.00 ➝ $341.00 | High | |
12/7/2020 | Morgan Stanley | Boost Target | Equal Weight | $270.00 ➝ $295.00 | Low | |
11/18/2020 | Needham & Company LLC | Reiterated Rating | Buy | $290.00 | Low | |
10/23/2020 | Barclays | Boost Target | Overweight | $287.00 ➝ $331.00 | Low | |
9/24/2020 | FBN Securities | Initiated Coverage | Outperform | $260.00 | Low | |
9/3/2020 | DA Davidson | Boost Target | Neutral | $215.00 ➝ $250.00 | High | |
9/3/2020 | Morgan Stanley | Boost Target | Equal Weight | $205.00 ➝ $270.00 | High | |
9/3/2020 | Needham & Company LLC | Boost Target | Buy | $259.00 ➝ $290.00 | High | |
9/3/2020 | Stifel Nicolaus | Boost Target | Buy | $225.00 ➝ $320.00 | High | |
9/3/2020 | Barclays | Boost Target | Overweight | $280.00 ➝ $287.00 | High | |
9/3/2020 | Citigroup | Boost Target | Buy | $275.00 ➝ $305.00 | High | |
9/3/2020 | The Goldman Sachs Group | Boost Target | Neutral | $215.00 ➝ $245.00 | High | |
9/3/2020 | Piper Sandler | Boost Target | Overweight | $226.00 ➝ $310.00 | High | |
9/2/2020 | Oppenheimer | Boost Target | Outperform | $240.00 ➝ $275.00 | High | |
6/24/2020 | The Goldman Sachs Group | Boost Target | Average ➝ Neutral | $169.00 ➝ $215.00 | Low | |
6/11/2020 | Morgan Stanley | Boost Target | Equal Weight | $203.00 ➝ $205.00 | Low | |
6/5/2020 | DA Davidson | Boost Target | Neutral | $105.00 ➝ $215.00 | Medium | |
6/5/2020 | Piper Sandler | Boost Target | Overweight | $138.00 ➝ $226.00 | High | |
6/5/2020 | Monness Crespi & Hardt | Downgrade | Buy ➝ Neutral | | High | |
6/5/2020 | Oppenheimer | Reiterated Rating | Buy | $140.00 ➝ $240.00 | High | |
6/2/2020 | Barclays | Boost Target | Overweight | $130.00 ➝ $275.00 | High | |
6/2/2020 | Needham & Company LLC | Boost Target | Buy | $170.00 ➝ $253.00 | High | |
6/1/2020 | Morgan Stanley | Boost Target | Equal Weight | $141.00 ➝ $203.00 | Low | |
5/28/2020 | Citigroup | Boost Target | Buy | $175.00 ➝ $275.00 | Medium | |
5/22/2020 | Stifel Nicolaus | Boost Target | Buy | $160.00 ➝ $225.00 | High | |
4/27/2020 | Needham & Company LLC | Lower Target | Buy | $172.00 ➝ $170.00 | Medium | |
4/19/2020 | Stifel Nicolaus | Boost Target | Buy | $135.00 ➝ $160.00 | High | |
3/18/2020 | Oppenheimer | Lower Target | | $155.00 ➝ $140.00 | High | |
3/18/2020 | Piper Sandler | Lower Target | | | High | |
3/18/2020 | DA Davidson | Lower Target | Neutral | $143.00 ➝ $105.00 | High | |
3/18/2020 | Needham & Company LLC | Lower Target | | $189.00 ➝ $172.00 | High | |
3/18/2020 | Monness Crespi & Hardt | Lower Target | Buy | $190.00 ➝ $150.00 | High | |
3/18/2020 | Citigroup | Lower Target | Buy | $200.00 ➝ $175.00 | High | |
3/18/2020 | Stifel Nicolaus | Lower Target | Hold | $185.00 ➝ $135.00 | High | |
3/16/2020 | Needham & Company LLC | Lower Target | Positive ➝ Buy | $189.00 ➝ $172.00 | High | |
1/27/2020 | Needham & Company LLC | Reiterated Rating | Buy | $189.00 | Medium | |
1/13/2020 | Morgan Stanley | Boost Target | Equal Weight | $160.00 ➝ $171.00 | Medium | |
1/6/2020 | Argus | Initiated Coverage | Hold | | High | |
12/10/2019 | Needham & Company LLC | Reiterated Rating | Buy | $189.00 | High | |
12/10/2019 | DA Davidson | Reiterated Rating | Neutral ➝ Positive | $143.00 | High | |
12/10/2019 | Morgan Stanley | Boost Target | Equal Weight | $150.00 ➝ $160.00 | High | |
12/10/2019 | Nomura Securities | Boost Target | Reduce | $76.00 ➝ $78.00 | High | |
10/28/2019 | Piper Jaffray Companies | Initiated Coverage | Overweight | $158.00 | Low | |
10/16/2019 | Morgan Stanley | Lower Target | Equal ➝ Equal Weight | $160.00 ➝ $150.00 | High | |
10/11/2019 | Oppenheimer | Lower Target | Outperform | $180.00 ➝ $155.00 | Low | |
9/6/2019 | Barclays | Reiterated Rating | Buy | | Low | |
9/5/2019 | Morgan Stanley | Boost Target | Equal Weight | $156.00 ➝ $160.00 | High | |
9/5/2019 | Barclays | Boost Target | Overweight | $178.00 ➝ $179.00 | High | |
9/5/2019 | Stifel Nicolaus | Boost Target | Buy | $180.00 ➝ $185.00 | High | |
9/5/2019 | Citigroup | Boost Target | Buy | $184.00 ➝ $195.00 | High | |
9/5/2019 | Needham & Company LLC | Set Target | Buy | $184.00 | High | |
9/4/2019 | KeyCorp | Set Target | Buy | $188.00 | Low | |
8/30/2019 | Monness Crespi & Hardt | Set Target | Buy | $185.00 | Low | |
8/30/2019 | Stifel Nicolaus | Set Target | Buy | $180.00 | Medium | |
8/28/2019 | Morgan Stanley | Boost Target | Equal Weight | $156.00 | Medium | |
8/27/2019 | Citigroup | Upgrade | Neutral ➝ Buy | $162.00 ➝ $184.00 | Medium | |
8/13/2019 | Compass Point | Initiated Coverage | Neutral ➝ Neutral | $155.00 | Medium | |
6/19/2019 | Nomura Securities | Set Target | Sell | $76.00 | High | |
6/19/2019 | Oppenheimer | Boost Target | Outperform | $160.00 ➝ $180.00 | Low | |
6/19/2019 | DA Davidson | Boost Target | | $165.00 | Medium | |
6/19/2019 | KeyCorp | Boost Target | Overweight | $165.00 ➝ $188.00 | High | |
6/19/2019 | William Blair | Reiterated Rating | Outperform | | High | |
6/19/2019 | Stifel Nicolaus | Boost Target | Buy ➝ Positive | $155.00 ➝ $180.00 | High | |
6/7/2019 | Morgan Stanley | Set Target | Hold | $156.00 | Medium | |
6/6/2019 | Nomura Securities | Boost Target | Reduce | $70.00 ➝ $76.00 | High | |
6/6/2019 | DA Davidson | Boost Target | Neutral | $140.00 | High | |
6/6/2019 | KeyCorp | Boost Target | Overweight | $150.00 ➝ $165.00 | High | |
6/6/2019 | Monness Crespi & Hardt | Reiterated Rating | Buy ➝ Buy | $150.00 ➝ $185.00 | High | |
6/4/2019 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $130.00 ➝ $159.00 | High | |
5/31/2019 | Citigroup | Set Target | Hold | $155.00 | High | |
5/23/2019 | Morgan Stanley | Boost Target | Equal Weight | $124.00 ➝ $153.00 | Low | |
5/15/2019 | Barclays | Boost Target | Overweight ➝ Overweight | $143.00 ➝ $178.00 | Medium | |
3/22/2019 | William Blair | Initiated Coverage | Outperform ➝ Outperform | | Medium | |
3/14/2019 | Citigroup | Boost Target | Neutral ➝ Neutral | $94.00 ➝ $116.00 | High | |
3/14/2019 | Stifel Nicolaus | Boost Target | Buy | $95.00 ➝ $130.00 | High | |
3/14/2019 | Monness Crespi & Hardt | Boost Target | Buy | $110.00 ➝ $150.00 | High | |
3/14/2019 | DA Davidson | Reiterated Rating | Neutral | | High | |
3/14/2019 | Needham & Company LLC | Reiterated Rating | Buy | $108.00 ➝ $130.00 | High | |
3/14/2019 | KeyCorp | Boost Target | Overweight ➝ Overweight | $100.00 ➝ $150.00 | High | |
3/13/2019 | JMP Securities | Reiterated Rating | Hold | | High | |
2/28/2019 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $91.00 ➝ $108.00 | Low | |
2/26/2019 | Nomura Securities | Set Target | Sell | $63.00 | Medium | |
12/14/2018 | Needham & Company LLC | Boost Target | Buy | $97.00 | Low | |
12/6/2018 | Needham & Company LLC | Boost Target | Buy ➝ Buy | $85.00 ➝ $91.00 | High | |
12/6/2018 | Citigroup | Boost Target | Neutral ➝ Neutral | $86.00 ➝ $94.00 | High | |
12/6/2018 | Monness Crespi & Hardt | Boost Target | Buy ➝ Buy | $90.00 ➝ $110.00 | High | |
10/17/2018 | CIBC | Initiated Coverage | Outperform ➝ Outperform | $80.00 | Low | |
10/17/2018 | Oppenheimer | Initiated Coverage | Outperform | $80.00 | Low | |
10/2/2018 | DA Davidson | Initiated Coverage | Neutral | $80.00 | Low | |
10/2/2018 | Nomura Securities | Downgrade | Neutral ➝ Reduce | $43.00 ➝ $63.00 | Low | |
9/17/2018 | Barclays | Boost Target | Overweight ➝ Overweight | $79.00 ➝ $105.00 | Low | |
9/12/2018 | BTIG Research | Initiated Coverage | Neutral | | Low | |
9/11/2018 | Citigroup | Boost Target | Neutral ➝ Neutral | $56.00 ➝ $86.00 | Low | |
9/6/2018 | Nomura Securities | Boost Target | Neutral ➝ Neutral | $40.00 ➝ $43.00 | High | |
9/6/2018 | Barclays | Reiterated Rating | Overweight ➝ Overweight | $72.00 ➝ $79.00 | High | |
9/6/2018 | Monness Crespi & Hardt | Boost Target | Buy ➝ Buy | $60.00 ➝ $90.00 | High | |
9/6/2018 | KeyCorp | Reiterated Rating | Overweight ➝ Overweight | $62.00 ➝ $88.00 | High | |
9/6/2018 | Stifel Nicolaus | Boost Target | Buy ➝ Buy | $53.00 ➝ $80.00 | High | |
9/4/2018 | Needham & Company LLC | Boost Target | Buy ➝ Buy | $57.00 ➝ $85.00 | High | |
8/30/2018 | Morgan Stanley | Boost Target | Equal Weight ➝ Equal Weight | $41.00 ➝ $66.00 | Medium | |
8/15/2018 | Barclays | Boost Target | Overweight ➝ Overweight | $57.00 ➝ $72.00 | Low | |
7/9/2018 | Rosenblatt Securities | Initiated Coverage | Buy | | Low | |
6/28/2018 | Citigroup | Initiated Coverage | Neutral | $56.00 | Low | |
6/12/2018 | Needham & Company LLC | Boost Target | Buy | $52.00 ➝ $57.00 | High | |
6/7/2018 | Stifel Nicolaus | Boost Target | Buy ➝ Buy | $47.00 ➝ $53.00 | Low | |
6/7/2018 | KeyCorp | Boost Target | Overweight ➝ Overweight | $50.00 ➝ $62.00 | Low | |
6/7/2018 | Monness Crespi & Hardt | Boost Target | Buy | $51.00 ➝ $60.00 | Low | |
6/7/2018 | Barclays | Boost Target | Overweight ➝ Overweight | $47.00 ➝ $57.00 | High | |
6/5/2018 | Morgan Stanley | Boost Target | Equal Weight ➝ Equal Weight | $35.00 ➝ $38.00 | Medium | |
6/5/2018 | Nomura Securities | Boost Target | Neutral | | Medium | |
6/4/2018 | Needham & Company LLC | Boost Target | Buy | $43.00 ➝ $52.00 | High | |
5/14/2018 | KeyCorp | Initiated Coverage | Overweight ➝ Overweight | $50.00 | Medium | |
4/11/2018 | Monness Crespi & Hardt | Initiated Coverage | Buy ➝ Buy | $51.00 | Low | |
4/5/2018 | Barclays | Boost Target | Overweight ➝ Overweight | $45.00 ➝ $47.00 | Low | |